Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1)
Adult (Early Phase 1)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma, Adenosquamous (Phase 1)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Chondrosarcoma (Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 2)
DNA Mismatch Repair (Phase 2)
Drug Evaluation (Phase 1)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Esophageal Neoplasms (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Gallbladder Neoplasms (Phase 1/Phase 2)
Gastrointestinal Neoplasms (Phase 1/Phase 2)
Genital Neoplasms, Female (Phase 1)
Giant Cell Tumor of Bone (Phase 2)
Glioblastoma (Early Phase 1)
Glioma (Early Phase 1)
Hamartoma (Phase 1/Phase 2)
Immunotherapy (Phase 1)
Intestinal Neoplasms (Phase 1/Phase 2)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 1)
Lymphocytes, Tumor-Infiltrating (Phase 1/Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Microsatellite Instability (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neoplasms, Squamous Cell (Phase 2)
Neuroendocrine Tumors (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Safety (Phase 1)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue